top of page
Robb Fujioka
Feb 22, 20242 min read
Science’s 2023 Breakthrough: GLP-1 Agonists Show Promise Against Obesity-Associated Disease
https://youtu.be/QnmMSMF7wO4?si=q_Z91vorvqBT1FSH Originally developed to treat type 2 diabetes nearly 20 years ago, the excitement...
20
bottom of page